Stallergenes Greer at a glance

Stallergenes Greer is a fully integrated global biopharmaceutical company

Stallergenes Greer is a global healthcare company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergy immunotherapy (AIT) products and services.

Our purpose: 

Enabling precision medicine to improve life for people with allergies

Our ambition:

Becoming the world's eading allergen immunotherapy company


The combination of Stallergenes SA and Greer Laboratories, Inc. has led to the creation of ONE Stallergenes Greer – a company with the largest finished AIT product manufacturing globally, an extensive global footprint and a product portfolio which offers solutions across the immunotherapy value chain.


2019 Company report

Click here to view 2019 Annual Report